Compare AVEX & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVEX | AORT |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2026 | 1996 |
| Metric | AVEX | AORT |
|---|---|---|
| Price | $10.98 | $23.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $31.89 | ★ $42.15 |
| AVG Volume (30 Days) | ★ 2.0M | 452.5K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ 0.01 | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $75.47 | $11.12 |
| Revenue Next Year | $20.33 | $10.77 |
| P/E Ratio | $1,093.14 | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $9.68 | $19.16 |
| 52 Week High | $23.62 | $48.25 |
| Indicator | AVEX | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 32.62 | 50.92 |
| Support Level | N/A | $22.83 |
| Resistance Level | $17.70 | $23.31 |
| Average True Range (ATR) | 1.06 | 0.98 |
| MACD | -0.35 | 0.34 |
| Stochastic Oscillator | 22.68 | 71.22 |
AEVEX Corp is a defense technology company delivering next-generation navigation and autonomy, uncrewed systems, and adaptable mission solutions engineered to need, delivered at speed, and built for the modern battlespace. Its solutions are sold to agencies and organizations within the DoW, SOF, IC, and allied international partners. The group offers products and solutions such as CompassCore, CompassVision, CompassEngage, Precision Strike Systems, Unmanned Surface Vessels, Long Endurance Aircraft, Additive Manufacturing, Full Spectrum Airborne ISR, Aircraft Modification and Testing, and Others.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.